KRBP logo

Kiromic BioPharma (KRBP) Net Income

KRBP Annual Net Income

-$20.95 M
+$13.78 M+39.68%

31 December 2023

KRBP Net Income Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

KRBP Quarterly Net Income

-$7.43 M
-$610.00 K-8.94%

30 September 2024

KRBP Quarterly Net Income Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

KRBP TTM Net Income

-$25.10 M
-$3.24 M-14.83%

30 September 2024

KRBP TTM Net Income Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

KRBP Net Income Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+39.7%-8.9%-14.8%
3 y3 years-9.1%-9.9%+19.0%
5 y5 years-449.0%-9.9%+19.0%

KRBP Net Income High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+39.7%-77.3%+37.3%-19.8%+34.5%
5 y5-year-462.0%+39.7%-301.3%+37.3%-573.3%+34.5%
alltimeall time-462.0%+39.7%-2551.6%+37.3%-6320.9%+34.5%

Kiromic BioPharma Net Income History

DateAnnualQuarterlyTTM
Sept 2024
-
-$7.43 M(+8.9%)
-$25.10 M(+14.8%)
June 2024
-
-$6.83 M(+11.0%)
-$21.86 M(+0.3%)
Mar 2024
-
-$6.15 M(+31.1%)
-$21.80 M(+4.0%)
Dec 2023
-$20.95 M(-39.7%)
-$4.69 M(+11.9%)
-$20.95 M(-10.2%)
Sept 2023
-
-$4.19 M(-38.0%)
-$23.33 M(-24.7%)
June 2023
-
-$6.76 M(+27.6%)
-$30.99 M(-5.1%)
Mar 2023
-
-$5.30 M(-25.0%)
-$32.66 M(-6.0%)
Dec 2022
-$34.73 M(+35.7%)
-$7.07 M(-40.4%)
-$34.73 M(-9.3%)
Sept 2022
-
-$11.86 M(+40.6%)
-$38.30 M(+17.6%)
June 2022
-
-$8.44 M(+14.5%)
-$32.56 M(+11.9%)
Mar 2022
-
-$7.37 M(-30.7%)
-$29.10 M(+13.7%)
Dec 2021
-$25.59 M
-$10.64 M(+73.6%)
-$25.59 M(+38.2%)
DateAnnualQuarterlyTTM
Sept 2021
-
-$6.12 M(+23.1%)
-$18.52 M(+25.0%)
June 2021
-
-$4.97 M(+29.1%)
-$14.81 M(-30.2%)
Mar 2021
-
-$3.85 M(+8.1%)
-$21.20 M(+10.4%)
Dec 2020
-$19.20 M(+415.0%)
-$3.56 M(+47.6%)
-$19.20 M(+7.8%)
Sept 2020
-
-$2.42 M(-78.7%)
-$17.80 M(+9.4%)
June 2020
-
-$11.37 M(+513.5%)
-$16.28 M(+213.6%)
Mar 2020
-
-$1.85 M(-14.6%)
-$5.19 M(+39.2%)
Dec 2019
-$3.73 M(-2.3%)
-$2.17 M(+144.6%)
-$3.73 M(+139.2%)
Sept 2019
-
-$886.90 K(+216.3%)
-$1.56 M(+132.1%)
June 2019
-
-$280.40 K(-28.3%)
-$671.30 K(+71.7%)
Mar 2019
-
-$390.90 K
-$390.90 K
Dec 2018
-$3.82 M
-
-

FAQ

  • What is Kiromic BioPharma annual net profit?
  • What is the all time high annual net income for Kiromic BioPharma?
  • What is Kiromic BioPharma annual net income year-on-year change?
  • What is Kiromic BioPharma quarterly net profit?
  • What is the all time high quarterly net income for Kiromic BioPharma?
  • What is Kiromic BioPharma quarterly net income year-on-year change?
  • What is Kiromic BioPharma TTM net profit?
  • What is the all time high TTM net income for Kiromic BioPharma?
  • What is Kiromic BioPharma TTM net income year-on-year change?

What is Kiromic BioPharma annual net profit?

The current annual net income of KRBP is -$20.95 M

What is the all time high annual net income for Kiromic BioPharma?

Kiromic BioPharma all-time high annual net profit is -$3.73 M

What is Kiromic BioPharma annual net income year-on-year change?

Over the past year, KRBP annual net profit has changed by +$13.78 M (+39.68%)

What is Kiromic BioPharma quarterly net profit?

The current quarterly net income of KRBP is -$7.43 M

What is the all time high quarterly net income for Kiromic BioPharma?

Kiromic BioPharma all-time high quarterly net profit is -$280.40 K

What is Kiromic BioPharma quarterly net income year-on-year change?

Over the past year, KRBP quarterly net profit has changed by -$610.00 K (-8.94%)

What is Kiromic BioPharma TTM net profit?

The current TTM net income of KRBP is -$25.10 M

What is the all time high TTM net income for Kiromic BioPharma?

Kiromic BioPharma all-time high TTM net profit is -$390.90 K

What is Kiromic BioPharma TTM net income year-on-year change?

Over the past year, KRBP TTM net profit has changed by -$3.24 M (-14.83%)